Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions

Conventional MRI can be limited in detecting subtle epileptic lesions or identifying active/epileptic lesions among widespread, multifocal lesions.

We developed a high-resolution 3D MR fingerprinting (MRF) protocol to simultaneously provide quantitative T₁ , T₂ , proton density, and tissue fraction maps for detection and characterization of epileptic lesions.

Prospective.

National Institute of Standards and Technology (NIST) / International Society for Magnetic Resonance in Medicine (ISMRM) phantom, five healthy volunteers and 15 patients with medically intractable epilepsy undergoing presurgical evaluation with noninvasive or invasive electroclinical data.

3D MRF scans and routine clinical epilepsy MR protocols were acquired at 3 T.

The accuracy of the T₁ and T₂ values were first evaluated using the NIST/ISMRM phantom. The repeatability was then estimated with both phantom and volunteers based on the coefficient of variance (CV). For epilepsy patients, all the maps were qualitatively reviewed for lesion detection by three independent reviewers (S.E.J., M.L., I.N.) blinded to clinical data. Region of interest (ROI) analysis was performed on T₁ and T₂ maps to quantify the multiparametric signal differences between lesion and normal tissues. Findings from qualitative review and quantitative ROI analysis were compared with patients' electroclinical data to assess concordance.

Phantom results were compared using R-squared, and patient results were compared using linear regression models.

The phantom study showed high accuracy with the standard values, with an R² of 0.99. The volunteer study showed high repeatability, with an average CV of 4.3% for T₁ and T₂ in various tissue regions. For the 15 patients, MRF showed additional findings in four patients, with the remaining 11 patients showing findings consistent with conventional MRI. The additional MRF findings were highly concordant with patients' electroclinical presentation.

The 3D MRF protocol showed potential to identify otherwise inconspicuous epileptogenic lesions from the patients with negative conventional MRI diagnosis, as well as to correlate with different levels of epileptogenicity when widespread lesions were present.

3. Technical Efficacy Stage: 3. J. Magn. Reson. Imaging 2019;49:1333-1346.